FDA Approves First-in-Class Drug for Follicular Lymphoma ...Middle East

Medscape - News
The first-in-class bispecific antibody mosunetuzumab-axgb (Lunsumio) has been granted an accelerated approval for use in relapsed or refractory follicular lymphoma. FDA Approvals

Hence then, the article about fda approves first in class drug for follicular lymphoma was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves First-in-Class Drug for Follicular Lymphoma )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News